Less invasive needle treatment could rival surgery for liver tumors
NCT ID NCT05129787
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments for colorectal cancer that has spread to the liver: surgical removal of tumors versus a less invasive needle ablation procedure guided by 3D imaging. 230 patients are randomly assigned to one of the two treatments. The goal is to see if ablation works as well as surgery in controlling tumor growth and improving survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Thermal ablation (needle ablation with 3D verification) and surgical resection
What this could lead to
If successful, this could show that needle ablation is as effective as surgery for treating liver metastases, offering a less invasive option with faster recovery.
What could go wrong
This is a single-center trial with 230 participants, and results may not apply to all patients. Ablation may have higher local recurrence rates than surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oslo University Hospital, Department of Gastrointestinal surgery, The National Hospital
Oslo, 0424, Norway